07/08/2025 15:20 Paper wrappers and curbside composting: The next 10 years of sustainable packaging
07/08/2025 15:20 ‘Nature positive’ is not a slogan – it’s an inspiring ambition and a measurable goal
07/08/2025 15:20 IBM’s sustainability chief: 3 strategic ways I’m using AI today
07/08/2025 13:20 China’s Oil Imports Jumped in July From a Year Earlier
07/08/2025 13:20 Trump Hints at Additional Tariffs on China Over Russian Oil Imports
07/08/2025 13:20 China’s Coal Imports Plunge 23% as Domestic Output Surges
07/08/2025 11:20 Aging Hiroshima Survivors Worry About Growing Nuke Threat On 80th Anniversary Of Bombing
07/08/2025 11:20 Netanyahu Meets Security Officials As Israel Considers Full Gaza Takeover
07/08/2025 11:20 Cavan Companies Expands Build-to-Rent Footprint in Casa Grande as Leasing Opens at Three New Communities
07/08/2025 07:20 Creole Shrimp and Sausage

Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs

Home » News » India » Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs

Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs

Jeff Grabmeier Ohio State University 06/03/2025 02:25

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, including hospitalizations and deaths, compared to their U.S.-made counterparts. Researchers uncovered this by matching drugs to their specific manufacturing plants, something the FDA does not disclose…

SciTechDaily
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, including hospitalizations and deaths, compared to their U.S.-made counterparts. Researchers uncovered this by matching drugs to their specific manufacturing plants, something the FDA does not disclose…
Read More